User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.


Ionis Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.52 -1.39% 36.81 16:07:01
Open Price Low Price High Price Close Price Prev Close
37.53 36.37 39.34 36.54 37.33
more quote information »

Recent News

Date Time Source Heading
5/06/202107:05PRNUSIonis to present at upcoming investor conferences
5/05/202116:05PRNUSIonis to host 2021 virtual annual meeting of stockholders
5/05/202114:59EDGARQuarterly Report (10-q)
5/05/202111:16EDGARCurrent Report Filing (8-k)
5/05/202108:06SEEKIonis Pharma trails Q1 consensus; top-line off 16%
5/05/202107:02SEEKIonis Pharmaceuticals EPS misses by $0.09, misses on revenue
5/05/202107:00PRNUSIonis reports first quarter 2021 financial results and..
5/04/202114:05SEEKIonis Pharmaceuticals Q1 2021 Earnings Preview
4/21/202107:05PRNUSIonis to hold first quarter 2021 financial results webcast
4/20/202107:32SEEKIonis begins pivotal study for ION373 in rare congenital..
4/20/202107:05PRNUSIonis initiates pivotal clinical study of novel antisense..
4/19/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202107:30GLOBEBiogen Advances Leading Research in Spinal Muscular Atrophy..
4/13/202106:06EDGARCurrent Report Filing (8-k)
4/08/202107:26SEEKIonis Pharmaceuticals prices upsized $550M convertible..
4/08/202107:05PRNUSIonis prices private placement of convertible senior notes
4/06/202116:36PRNUSIonis announces proposed private placement of convertible..
4/06/202108:07SEEKProgenity and Ionis ink collaboration agreement
4/06/202107:01EDGARCurrent Report Filing (8-k)
4/05/202109:02SEEKIonis initiates rare neurodegenerative disorder late-stage..
4/05/202107:05PRNUSIonis initiates Phase 3 trial of novel antisense medicine to..
3/29/202110:24EDGARCurrent Report Filing (8-k)
3/29/202107:32SEEKIonis Pharma's antisense med successful in mid-stage HAE..
3/29/202107:05PRNUSIonis reports positive topline Phase 2 study results of its..
3/26/202107:05PRNUSIonis to present at upcoming investor conferences
3/25/202111:51TRMNAnalysts See an ‘Attractive Entry Point’ in These 3 Stocks
3/23/202108:30SEEKQuantumScape, MP Materials among premarket losers' pack
3/23/202107:15DJNIonis Pharmaceuticals Partner Stops Dosing in Huntington's..
3/23/202106:06EDGARCurrent Report Filing (8-k)
3/22/202116:01PRNUSIonis' partner provides update on clinical studies..
3/01/202107:05PRNUSIonis establishes new grant program to advance research and..
2/24/202107:04SEEKIonis Pharmaceuticals EPS misses by $2.70, beats on revenue
2/24/202107:00PRNUSIonis reports fourth quarter and full year 2020 financial..
2/23/202111:17SEEKIonis Pharmaceuticals Q4 2020 Earnings Preview
2/19/202107:05PRNUSIonis to present at upcoming investor conferences
2/16/202112:25EDGARStatement of Ownership (sc 13g)
2/12/202116:10EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202107:05PRNUSIonis to hold 2020 financial results webcast
2/10/202111:17EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202117:24EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202110:26EDGARAmended Statement of Ownership (sc 13g/a)
2/05/202107:54EDGARAmended Statement of Ownership (sc 13g/a)
2/01/202117:47EDGARStatement of Changes in Beneficial Ownership (4)
1/20/202118:56EDGARStatement of Changes in Beneficial Ownership (4)
1/15/202117:56EDGARStatement of Changes in Beneficial Ownership (4)
1/08/202107:30GLOBEBiogen Announces First Patient Treated in RESPOND Study..
1/07/202117:30PRNUSIonis appoints Eugene Schneider, M.D., as executive vice..
12/28/202017:30EDGARStatement of Changes in Beneficial Ownership (4)
12/17/202018:30PRNUSStanley T. Crooke, Ph.D., M.D, to retire from Ionis to focus..
12/08/202021:15PRNUSIonis highlights achievements, commercial strategy and..
See more news about this stock »
Your Recent History
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210507 20:22:35